222 related articles for article (PubMed ID: 36705724)
1. Management of infantile hemangiomas-experience of a tertiary hospital.
Gomes R; Salazar L; Fraga C; Correia MR; Barbosa-Sequeira J; Fernandes A; Álvares S; Banquart Leitão J; Paiva Coelho M
Eur J Pediatr; 2023 Apr; 182(4):1611-1618. PubMed ID: 36705724
[TBL] [Abstract][Full Text] [Related]
2. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
[TBL] [Abstract][Full Text] [Related]
3. Treatment of problematic infantile hemangiomas with propranolol: a series of 40 cases and review of the literature.
Oksiuta M; Matuszczak E; Dębek W; Dzienis-Koronkiewicz E; Hermanowicz A; Tylicka M
Postepy Hig Med Dosw (Online); 2014 Sep; 68():1138-44. PubMed ID: 25228522
[TBL] [Abstract][Full Text] [Related]
4. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid.
López-Gutiérrez JC
Eur J Pediatr; 2019 Jan; 178(1):1-6. PubMed ID: 30421264
[TBL] [Abstract][Full Text] [Related]
5. Predictors of poor response to oral propranolol in infantile hemangiomas.
Hali F; Moubine I; Berrami H; Serhier Z; Othmani MB; Chiheb S
Arch Pediatr; 2023 Oct; 30(7):455-457. PubMed ID: 37394367
[TBL] [Abstract][Full Text] [Related]
6. Retrospective analysis of beta-blocker instituted for treatment of hemangiomas (RABBIT study).
Chu DH; Castelo-Soccio L; Wan J; Gelfand JM; Shaddy RE; Shah KN; Perman MJ; Treat JR; Yan AC
Clin Pediatr (Phila); 2014 Oct; 53(11):1084-90. PubMed ID: 24849505
[TBL] [Abstract][Full Text] [Related]
7. Propranolol therapy for infantile hemangioma: our experience.
Zhang L; Wu HW; Yuan W; Zheng JW
Drug Des Devel Ther; 2017; 11():1401-1408. PubMed ID: 28507428
[TBL] [Abstract][Full Text] [Related]
8. Retrospective case series of increased oral propranolol dosage for infantile hemangiomas.
Huang AH; Mannschreck D; Aggarwal P; Mahon M; Cohen BA
Pediatr Dermatol; 2020 Nov; 37(6):1057-1062. PubMed ID: 32869385
[TBL] [Abstract][Full Text] [Related]
9. Infantile Hemangioma: A Current Review.
Pahl KS; McLean TW
J Pediatr Hematol Oncol; 2022 Mar; 44(2):31-39. PubMed ID: 34966091
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of infantile hemangiomas.
Püttgen KB
Pediatr Clin North Am; 2014 Apr; 61(2):383-402. PubMed ID: 24636652
[TBL] [Abstract][Full Text] [Related]
11. Beta blocker treatment for infantile hemangiomas.
Rouhana HF; Fruge JH; Massengale WT
Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436966
[TBL] [Abstract][Full Text] [Related]
12. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients.
Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N
Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601
[TBL] [Abstract][Full Text] [Related]
13. Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas.
Kim LHC; Hogeling M; Wargon O; Jiwane A; Adams S
J Pediatr Surg; 2011 Apr; 46(4):759-763. PubMed ID: 21496551
[TBL] [Abstract][Full Text] [Related]
14. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(2):115-21. PubMed ID: 22513064
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
[TBL] [Abstract][Full Text] [Related]
16. [Chinese experts consensus on the use of oral propranolol for treatment of infantile hemangiomas].
Zheng JW; Wang XK; Qin ZP; Fan XD; Li K; Yang YW; Huo R; Liu SH; Zhao JH; Wang XY; Zhou DK
Shanghai Kou Qiang Yi Xue; 2016 Jun; 25(3):257-60. PubMed ID: 27609372
[TBL] [Abstract][Full Text] [Related]
17. Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience.
El Hachem M; Gesualdo F; Diociaiuti A; Berti I; Vercellino N; Boccaletti V; Neri I; Porcedda G; Greco A; Carnevale C; Oranges T; Cutrone M; Dalmonte P
Ital J Pediatr; 2017 Apr; 43(1):40. PubMed ID: 28424095
[TBL] [Abstract][Full Text] [Related]
18. Treatment for Infantile Hemangiomas: Selection Criteria, Safety, and Outcomes Using Oral Propranolol During the Early Phase of Propranolol Use for Hemangiomas.
MacIsaac ZM; Nayar HS; Gehris R; Mehta D; Geisler S; Grunwaldt LJ
J Craniofac Surg; 2016 Jan; 27(1):159-62. PubMed ID: 26674892
[TBL] [Abstract][Full Text] [Related]
19. Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas.
Mannschreck DB; Huang AH; Lie E; Psoter K; Puttgen K
Pediatr Dermatol; 2019 May; 36(3):283-289. PubMed ID: 30968438
[TBL] [Abstract][Full Text] [Related]
20. Immediate possible adverse event rates in infants treated with oral propranolol for infantile haemangiomas at an Australian urban tertiary hospital between 2016 and 2019.
Adams L; Ryan E
Australas J Dermatol; 2022 Nov; 63(4):473-478. PubMed ID: 35938573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
